ESG

A new oral drug, IMSB301, offers hope for Aicardi Goutières Syndrome, a devastating rare disease with no cure, in a pivotal new clinical trial.

Clinical-stage biotech BioVie announces its novel anti-inflammatory drug, bezisterim, will be featured at a key psychiatric conference for its potential.

With promising new data for its cancer and obesity pipeline, Corbus Pharmaceuticals prepares for a crucial investor presentation at the Oppenheimer conference.

Skycorp Solar reported a 27% revenue surge driven by global expansion, but intense competition and rising costs led to a surprising net loss.

Compugen adds strategic powerhouse Dr. Michele Holcomb to its board, a move signaling its ambition to convert AI-driven discoveries into market value.

A new paint from Adept Materials uses advanced physics to passively regulate indoor humidity, promising healthier homes and lower energy bills.

Operating as quietly as a library, Hoymiles' new HoyUltra 2 battery overcomes noise barriers, poised to accelerate clean energy projects in cities.

Geotab's new GO Focus Pro dash cam uses 360-degree views and predictive AI to empower drivers, cut costs, and make roads safer for commercial fleets.

Hong Kong's exchange appoints Jalal Almarhoon to spearhead its Riyadh office, signaling a major strategic move to link Asian and Middle Eastern capital.

A new report reveals a 17% gender pay gap in Türkiye's fashion sector, driven by systemic issues, not unequal pay for equal work. What does this mean for your clothes?

A vibrant cultural showcase in Ethiopia highlights China's strategy to deepen Africa ties through soft power, moving beyond economics to win hearts and minds.

The VR firm projects major growth, leveraging its subscription model and a key role in the global nuclear energy revival with its digital twin technology.

A new drug, JIN-A02, shows early promise in overcoming resistance to common lung cancer therapies, even shrinking hard-to-treat brain metastases.

The vaccine maker posts record 2025 earnings on mpox demand but signals a strategic shift, prioritizing its travel vaccine portfolio over new R&D.

Taiwan's largest financial group is betting big on tech, talent, and regulatory tailwinds to become a dominant force in Asian asset management.

The French biopharma giant posts strong 2025 results and forecasts over 13% growth, fueled by a booming pipeline and unexpected market advantages.

A potential first therapy for Charcot-Marie-Tooth disease heads to a major conference, showing promising functional gains despite missing its primary goal.

A new index reveals Indian small businesses are aggressively implementing sustainability, driven by profit motives, despite a surprising dip in awareness.

New data reveals Mesoblast's cell therapy Ryoncil dramatically boosts survival in GvHD patients when used early, paving the way for a major adult trial.

The specialty food giant adds Suntory Global Spirits CEO Greg Hughes to its board, a strategic move to leverage premium brand and operational expertise.